Literature DB >> 28507656

Development of a Pharmacist REferral Program in a primary cARE clinic (PREPARE): A prospective cross-sectional study.

Arden R Barry1.   

Abstract

BACKGROUND: Increasing demand for ambulatory health care services has led to the development of primary care multidisciplinary teams that include pharmacists. The objective of this study was to characterize referrals to a pharmacist in a primary care clinic (PCC) based in Chilliwack, British Columbia.
METHODS: This prospective cross-sectional study included all patients referred to the PCC pharmacist over 12 months (May 2015 to April 2016). Data regarding the source/reason for referral, patient demographics, medical problems/medications and number/category of identified drug therapy concerns (DTCs) were collected.
RESULTS: A total of 137 referrals were received. Mean age was 60 years and 59% were female. Twenty patients (15%) did not attend their appointment. Fifty-eight percent were new clinic patients identified using a Medication Risk Assessment Questionnaire (MRAQ), 30% were from PCC clinicians and 12% were from community family physicians. The most common reason for referral was for a medication review (82%). Median number of medical problems and medications per patient were 7 (interquartile range [IQR] 5) and 11 (IQR 7.5), respectively. A total of 460 DTCs were identified (median 4 per patient, IQR 3.5), of which 34% were medication without an indication and 28% an untreated indication. DISCUSSION AND
CONCLUSION: The most common source of referrals to a PCC pharmacist was for medication reviews of new patients using an MRAQ. Most referred patients had multiple medical problems and polypharmacy, and few were referred for disease-specific management. The number of DTCs per patient was variable and, despite polypharmacy being commonplace, almost one-third of patients had an untreated indication.

Entities:  

Year:  2017        PMID: 28507656      PMCID: PMC5415068          DOI: 10.1177/1715163517702167

Source DB:  PubMed          Journal:  Can Pharm J (Ott)        ISSN: 1715-1635


  21 in total

1.  Pharmacist intervention in primary care to improve outcomes in patients with left ventricular systolic dysfunction.

Authors:  Richard Lowrie; Frances S Mair; Nicola Greenlaw; Paul Forsyth; Pardeep S Jhund; Alex McConnachie; Brian Rae; John J V McMurray
Journal:  Eur Heart J       Date:  2011-11-14       Impact factor: 29.983

2.  Pharmacist-driven renal medication dosing intervention in a primary care patient-centered medical home.

Authors:  Kelli D Barnes; Neeraj H Tayal; Amy M Lehman; Stuart J Beatty
Journal:  Pharmacotherapy       Date:  2014-10-25       Impact factor: 4.705

3.  Pharmacist involvement in primary care improves hypertensive patient clinical outcomes.

Authors:  Phayom Sookaneknun; Robert M E Richards; Jaratbhan Sanguansermsri; Chai Teerasut
Journal:  Ann Pharmacother       Date:  2004-11-02       Impact factor: 3.154

4.  Adding pharmacists to primary care teams reduces predicted long-term risk of cardiovascular events in type 2 diabetic patients without established cardiovascular disease: results from a randomized trial.

Authors:  N N Ladhani; S R Majumdar; J A Johnson; R T Tsuyuki; R Z Lewanczuk; R Spooner; S H Simpson
Journal:  Diabet Med       Date:  2012-11       Impact factor: 4.359

5.  Adding pharmacists to primary care teams increases guideline-concordant antiplatelet use in patients with type 2 diabetes: results from a randomized trial.

Authors:  Fizza Gilani; Sumit R Majumdar; Jeffrey A Johnson; Ross T Tsuyuki; Richard Z Lewanczuk; Richard Spooner; Scot H Simpson
Journal:  Ann Pharmacother       Date:  2013-01-16       Impact factor: 3.154

6.  Integrating pharmacists into family practice teams: physicians' perspectives on collaborative care.

Authors:  Kevin Pottie; Barbara Farrell; Susan Haydt; Lisa Dolovich; Connie Sellors; Natalie Kennie; William Hogg; Carmel M Martin
Journal:  Can Fam Physician       Date:  2008-12       Impact factor: 3.275

7.  Assessment of clinical pharmacist management of lipid-lowering therapy in a primary care setting.

Authors:  L Traywick Till; John C Voris; Julian Bourne Horst
Journal:  J Manag Care Pharm       Date:  2003 May-Jun

8.  A cluster randomised controlled trial of a pharmacist-led collaborative intervention to improve statin prescribing and attainment of cholesterol targets in primary care.

Authors:  Richard Lowrie; Suzanne M Lloyd; Alex McConnachie; Jill Morrison
Journal:  PLoS One       Date:  2014-11-18       Impact factor: 3.240

Review 9.  The effect of pharmacist-led interventions in optimising prescribing in older adults in primary care: A systematic review.

Authors:  David O Riordan; Kieran A Walsh; Rose Galvin; Carol Sinnott; Patricia M Kearney; Stephen Byrne
Journal:  SAGE Open Med       Date:  2016-06-14

10.  Feasibility of a self-administered survey to identify primary care patients at risk of medication-related problems.

Authors:  Mark J Makowsky; Andrew J Cave; Scot H Simpson
Journal:  J Multidiscip Healthc       Date:  2014-02-22
View more
  2 in total

1.  Development of a pharmacist-led internal medicine outpatient consult service.

Authors:  Ricky D Turgeon; Nilu Partovi; Karen Dahri; Laura Kuyper; Charles Au
Journal:  Can Pharm J (Ott)       Date:  2021-01-19

2.  Factors influencing the acceptance of referrals for clinical pharmacist managed disease states in primary care.

Authors:  Shubha Bhat; Miranda Kroehl; Whitley M Yi; Jaclyn Jaeger; Angela M Thompson; H Mindy Lam; Danielle Loeb; Katy E Trinkley
Journal:  J Am Pharm Assoc (2003)       Date:  2019-04-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.